Mouse CD229/SLAMF3 Protein (LY9-MM101)
Mouse CD229/SLAMF3 Protein (LY9-MM101)
  • Express System: HEK293
  • Product Tag: C-His
  • Purity: > 95% as determined by Bis-Tris PAGE;> 95% as determined by HPLC
  • Amino Acid Range: Lys48-Arg453
Catalog #LY9-MM101
Regular price $315.00
/
Size

Order now, ships by:

Product Description
Recombinant Mouse CD229/SLAMF3 Protein is expressed from HEK293 with His tag at the C-terminus.It contains Lys48-Arg453.
Product Background
CD229 was strongly and homogeneously overexpressed on the PC of patients with monoclonal gammopathy of undetermined significance (MGUS), smoldering myeloma, MM, and PC leukemia. CD229 was particularly overexpressed on those PC showing an abnormal phenotype such as expression of CD56. Most importantly, CD229 was also highly expressed on those cells in the patients' BM displaying the phenotype of chemotherapy-resistant and myeloma-propagating cells.
Product Category
Recombinant Protein
Target
CD229/SLAMF3
Accession
Species
Mouse
Biotinylated
no
Amino Acid Range
Lys48-Arg453
Molecular Weight
The protein has a predicted MW of 46.19 kDa. Due to glycosylation, the protein migrates to 60-80 kDa based on Bis-Tris PAGE result.
Product Tag
C-His
Express System
HEK293
Purity
> 95% as determined by Bis-Tris PAGE;> 95% as determined by HPLC
Endotoxin
Less than 1EU per ug by the LAL method.
Form
Lyophilized
Shipping
Shipped at ambient temperature.
Formulation
Lyophilized from 0.22 um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization.
Reconstitution
Centrifuge the tube before opening. Reconstituting to a concentration more than 100 ug/ml is recommended. Dissolve the lyophilized protein in distilled water.
Stability And Storage
Reconstituted protein stable at -80°C for 12 months, 4°C for 1 week. Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
Mouse CD229 on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.
The purity of Mouse CD229 is greater than 95% as determined by SEC-HPLC.
Recently viewed